Epidermal skin grafting in vitiligo: a pilot study

Area of Science:

• Dermatology
• Regenerative Medicine

Background:

• Vitiligo is a skin condition causing depigmentation due to melanocyte loss.
• Current surgical treatments for stable vitiligo can be invasive and have drawbacks.
• Advanced therapies are sought to improve treatment outcomes and patient quality of life.

Observation:

• A novel automated epidermal skin harvesting system (CELLUTOME™) was evaluated.
• The system harvests micrografts without local anesthesia or pre-treatment.
• It demonstrated low donor site morbidity in preliminary assessments.

Findings:

• The automated system proved safe and effective for harvesting melanocyte-containing micrografts.
• This method is suitable for patients with stable vitiligo unresponsive to conventional therapies.
• A minimum 12-month follow-up confirmed clinical safety and efficacy.

Implications:

• This technology offers a less invasive surgical option for vitiligo treatment.
• Accelerated repigmentation and improved patient quality of life are potential benefits.
• Cost-effectiveness and reduced patient discomfort may be achieved with this advanced therapy.